This thread is going to be a collection of all my #globaloncology papers, primarily for my own reference to bookmark for quick access but also, just in case, it is helpful for any colleague with an interest in global oncology. 1/
This is one such article that I actually feel quite proud of having written. My first single author paper but I had the huge opportunity to receive the mentorship of Dr. Len Saltz for this piece. Many thanks to JCO GO @ASCO_pubs for that opportunity. https://ascopubs.org/doi/10.1200/JGO.2015.000588
This was a provocative paper but seeing LMICs spend their limited resources on unproven expensive screening modalities compelled me to write this w/ @KAZ99081 : https://link.springer.com/article/10.1007/s10552-016-0812-8
Another example of jugaad led by @Poudyalbishesh . The title says it all. https://onlinelibrary.wiley.com/doi/abs/10.1111/hae.13017
This one was published in Journal of Nepal Medical Association. Yes, we do have a Pubmed indexed medical journal in Nepal :) http://jnma.com.np/jnma/index.php/jnma/article/view/2832 Again led by @Poudyalbishesh
This piece explores the issues surrounding the inaffordability of avastin for advanced cervical cancer in LMICs like Nepal. https://ascopubs.org/doi/full/10.1200/JGO.2016.004895
This is another paper that I’m particularly proud of. We explore the economic issues with new cancer drugs here. My first opportunity to work with the inspirational mentor @SullivanProf https://www.tandfonline.com/doi/full/10.1080/20502877.2017.1314885
Yes, cancer drugs are cheaper in LMICs. But that doesn’t mean that they’re affordable. https://www.oncotarget.com/article/21976/pdf/
This is probably The most important paper in #globaloncology I’ve ever written. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30076-7/fulltext
This perspective piece in @TheLancetOncol didn’t earn me many friends but this was a question that needed asking. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30269-9/fulltext
This is as relevant today as it was when published. What #globaloncology needs is More Funding and Mutual Learning. https://ascopubs.org/doi/full/10.1200/JGO.17.00237
Is a suboptimal approach to cancer screening better than no screening at all? @ramsedhom and I try to discuss this in reference to breast cancer screening in LMICs in this piece @JournalofEthics : https://journalofethics.ama-assn.org/article/when-suboptimal-approach-cancer-screening-better-none/2020-02
And finally, this paper with @Simple_Trials et al. in @NatureCancer explores the challenges and opportunities for cancer clinical trials in LMICs. https://www.nature.com/articles/s43018-020-0030-x
Forgot to add this recent paper in @JAMAOnc which discusses how HICs can learn from #LMICs about prioritization in cancer care necessary during the pandemic. https://jamanetwork.com/journals/jamaoncology/fullarticle/2767424
Adding this recently published work to the thread: https://twitter.com/oncology_bg/status/1289298490846109696?s=21 https://twitter.com/oncology_bg/status/1289298490846109696
Adding this new paper to the list: https://twitter.com/oncology_bg/status/1298052235654565890
About addressing the mental health challenges of cancer care workers in LMICs during the pandemic. https://twitter.com/oncology_bg/status/1313215597405241347
You can follow @oncology_bg.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: